Patents by Inventor Yanping Hu

Yanping Hu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240168588
    Abstract: The present invention relates to a touch display device, a drive control circuit for the touch display device, and a method for operating the touch display device. The touch display device includes a drive control circuit, the drive control circuit is configured to: in a display phase, provide a common voltage signal to a common electrode in a pixel circuit of the touch display device; in a touch phase, provide a touch drive signal to the common electrode, wherein a ratio of an average value of a high level and a low level of the touch drive signal to a value of the common voltage signal ranges from 0.8 to 1.2.
    Type: Application
    Filed: June 25, 2021
    Publication date: May 23, 2024
    Inventors: Yinlong ZHANG, Zhihua SUN, Pengfei HU, Senwang LI, Yanping LIAO, Xibin SHAO, Xiaofeng YIN, Jiantao LIU, Kaiming SHI, Jinling ZHANG
  • Patent number: 11976129
    Abstract: A monoclonal antibody specifically binding to human and monkey CD38 antigens or a derivative thereof includes: antigen complementarity-determining regions CDR1, CDR2 and CDR3 of an antibody light chain variable region having amino acid sequences as set forth in SEQ ID NO: 3, SEQ ID NO: 4 and SEQ ID NO: 5, respectively; and antigen complementarity-determining regions CDR1, CDR2 and CDR3 of an antibody heavy chain variable region having amino acid sequences as set forth in SEQ ID NO: 8, SEQ ID NO: 9 and SEQ ID NO: 10, respectively. The monoclonal antibody or derivative thereof can be used as a component of a pharmaceutical composition or prepared into a suitable pharmaceutical preparation, administered alone or combined with other therapeutic means such as chemotherapy drugs, for treating tumors with positive CD38 expression, such as human myeloma and human lymphoma.
    Type: Grant
    Filed: September 27, 2018
    Date of Patent: May 7, 2024
    Assignee: ACROIMMUNE BIOTECH CO., LTD.
    Inventors: Hongqun Hu, Xiaoqi Song, Zui Chen, Xiaoxiao Ma, Yanping Yuan, Qunmin Zhou
  • Publication number: 20110280827
    Abstract: The invention relates to methods and compositions for treating a subject afflicted with a hematological malignancy using a combination of a CXCR4 antagonist and an immunotherapeutic agent.
    Type: Application
    Filed: January 28, 2010
    Publication date: November 17, 2011
    Inventors: Yanping Hu, William Siders, Johanne Kaplan